1/4

Export Ready

Docetaxel anhydrous

Name: Docetaxel anhydrous
SKU: 8494547
Price: 10882.44 USD
Availability: InStock

Sold by avd pharmaceuticals private limited · Service Provider , Manufacturer, Distributor, Exporter, Startup · Pimpri-Chinchwad, Maharashtra, India

Price

₹ 10,882.44 /Centimetre

In stock

MRP ~~₹ 13,603.05~~

Inclusive of all taxes

You Save: ₹ 2,720.61

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

1 to 10 grams per vial, as per regulatory requirements

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for avd pharmaceuticals private limited.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Pimpri-Chinchwad Dispatch on request Verified seller

avd pharmaceuticals private limited

Service Provider , Manufacturer, Distributor, Exporter, Startup · Pimpri-Chinchwad, Maharashtra, India

Manufacturer of Research Chemicals, Drug Substances, Drug Intermediates, Impurities, Specialty Chemicals, and Provider of Job Work & Toll Manufacturing Services for Pharmaceutical and Chemical Companies

Registered address: Pune, India. Industry: Chemicals, Dyes & Paints > Chemicals, Compounds & Formulations.

View profile All products

Established

2022

Employees

11–30

GST

27AAXCA5614Q1ZS

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Jun 2025

Turnover

10000001 - 50000000.

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Docetaxel anhydrous is a potent anti-cancer drug used primarily in chemotherapy for breast, lung, and prostate cancers. It functions by inhibiting microtubule depolymerization, disrupting cell division. Manufactured under strict GMP guidelines, this API is used in the formulation of injectable solutions. Its anhydrous form offers superior stability and purity for medical applications.

Product Description

Docetaxel Anhydrous

Docetaxel is a semi-synthetic chemotherapeutic agent belonging to the taxane family, primarily used in the treatment of various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer. It is derived from a precursor found in the needles of the European yew tree (Taxus baccata). Docetaxel works by inhibiting cell division through the stabilization of microtubules, preventing their disassembly, which is essential for mitosis.

Product Summary:

CAS Number: 114977-28-5
Molecular Formula: C43H53NO14
Molecular Weight: 807.88 g/mol
Synonyms: Taxotere
Packaging: As per regulatory requirements (usually 1–10 g vials)
Solubility: Soluble in ethanol and polysorbates
Storage: Refrigerated; protect from light
Toxicity: Cytotoxic; handle with gloves and in sterile conditions

Applications:

Oncology – breast, lung, prostate cancers
Chemotherapeutic API
Research in cancer biology

Description provided by avd pharmaceuticals private limited.

Specifications

CAS Number	114977-28-5
Molecular Formula	C43H53NO14
Molecular Weight	807.88 g/mol
Synonyms	Taxotere
Physical State	Anhydrous solid powder
Packaging	1 to 10 grams per vial, as per regulatory requirements
Solubility	Ethanol soluble; soluble in polysorbates
Storage	Store refrigerated, protect from light
Handling Precautions	Use gloves and conduct all work under sterile, cytotoxic safety protocols

Use cases

Category	healthcare > drugs and medicine
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	1 to 10 grams per vial, as per regulatory requirements
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Docetaxel anhydrous. Answers compiled from verified sellers' commercial terms and platform data.

Q: What advantages does the anhydrous form of Docetaxel offer in pharmaceutical formulations?

A: The anhydrous form of Docetaxel provides enhanced chemical stability and purity compared to hydrated forms, allowing longer shelf life, reduced degradation, and more consistent dosing in injectable chemotherapy formulations.

Q: How is Docetaxel anhydrous handled safely during manufacturing?

A: Due to its cytotoxicity, Docetaxel anhydrous must be handled in sterile clean-room environments using protective gloves and equipment to prevent exposure and cross-contamination, ensuring operator and product safety.

Q: What solvents is Docetaxel anhydrous compatible with for formulation purposes?

A: Docetaxel anhydrous is soluble primarily in ethanol and in polysorbate solvents, which are commonly used for preparing injectable chemotherapy solutions.

Q: What typical packaging sizes are available for Docetaxel anhydrous in API form?

A: Docetaxel anhydrous is typically supplied in regulatory-compliant vials ranging from 1 gram to 10 grams, tailored for pharmaceutical manufacturing batch sizes.

Q: What cancers is Docetaxel anhydrous primarily used to treat?

A: Docetaxel anhydrous is primarily used in chemotherapy for breast, lung, and prostate cancers due to its mechanism of inhibiting cancer cell division.

Question not answered? Ask sellers directly — typical response within 4 hours.